(6-195) Systematic Review of Anthropometric Measurements, Metabolic Outcomes, and Safety of GLP-1 Agonists and GLP-1/GIP Dual Agonists on Diabetic and Non-Diabetic Overweight or Obese Patients
Tuesday, December 6, 2022
10:45 AM – 11:45 AM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Chronic/Managed Care